Gilead Sciences GILD
NASDAQ GILD
$146.39 +2.95 (+2.06%)
As of: Aug 21, 2026 · 2:45 PM EDT

Gilead Sciences (GILD) Operating Margin Growth (3y) (2012 - 2026)

Gilead Sciences (GILD) Operating Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Johnson & Johnson 652.87 Bn 632.12 Bn 17.26 Bn 120.00
2 AbbVie 470.09 Bn 463.52 Bn 12.70 Bn 531.00
3 Merck 375.69 Bn 368.55 Bn 12.21 Bn 3,082.00
4 Novartis Ag 303.40 Bn 295.71 Bn 11.24 Bn 842.00
5 Astrazeneca 257.51 Bn 252.61 Bn 12.86 Bn -95.00
6 Amgen 236.27 Bn 222.28 Bn 7.24 Bn -347.00
7 Gilead Sciences 181.86 Bn 178.68 Bn 6.22 Bn -15,844.00
8 Pfizer 159.32 Bn 147.62 Bn 10.94 Bn 20,333.00
9 Gsk 106.16 Bn 101.99 Bn 8.24 Bn -2,411.00
10 Sanofi 55.12 Bn 47.74 Bn 10.79 Bn 471.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -15,844.00
Mar 31, 2026 1,031.00
Dec 31, 2025 -565.00
Sep 30, 2025 254.00
Jun 30, 2025 252.00
Mar 31, 2025 3,056.00
Dec 31, 2024 1,942.00
Sep 30, 2024 -4,000.00
Jun 30, 2024 189.00
Mar 31, 2024 -10,964.00
Dec 31, 2023 -1,306.00
Sep 30, 2023 678.00
Jun 30, 2023 8,323.00
Mar 31, 2023 -1,645.00
Dec 31, 2022 1,209.00
Sep 30, 2022 6,657.00
Jun 30, 2022 -1,033.00
Mar 31, 2022 -3,937.00
Dec 31, 2021 -676.00
Sep 30, 2021 490.00